Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes
Segar MW, Kolkailah AA, Frederich R, et al.
Diabetes Obes Metab. Pub. online 23 May 2022.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis
Karagiannis T, Avgerinos I, Liakos A, et al.
Diabetologia. Pub. online 17 May 2022.
Leggi
Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada
Marfil-Garza BA, Imes S, Verhoeff K, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00114-0.
Leggi
Risk factors for lower bone mineral density in older adults with type 1 diabetes: a cross-sectional study
Schwartz AV, Backlund JYC, de Boer IH, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00103-6.
Leggi
Direct and indirect costs of heart failure respective of diabetes status – a nationwide study
Bundgaard J, Mogensen UM, Christensen S et al
NMCD. Pub. online 19 May 2022
Leggi
Symptoms and glycemic control in young people with type 1 diabetes following SARS-CoV-2 infection: an observational study
Nimri R, Marianna R, Yackobovitch-Gavan M, et al.
J Clin Endocrinol Metab. 2022;dgac288. Pub. online 7 May 2022.
Leggi
Severe hypoglycemia increases dementia risk and related mortality: a nationwide, population-based cohort study
Han E, Han Kd, Lee BW, et al.
J Clin Endocrinol Metab. 2022;107(5):e1976-e1986.
Leggi
Prevalence of vertebral fractures in adults with type 1 diabetes: DenSiFy study (Diabetes Spine Fractures)
Coll JC, Garceau E, Leslie WD, et al.
J Clin Endocrinol Metab. 2022;107(5):e1860-e1870.
Leggi
Guidelines for cardiovascular risk reduction in patients with type 2 diabetes: JACC guideline comparison
Kelsey MD, Nelson AJ, Green JB, et al.
J Am Coll Cardiol. 2022;79(18):1849-57.
Leggi
Association of glucagon-like peptide-1 receptor agonist use with risk of gallbladder and biliary diseases: a systematic review and meta-analysis of randomized clinical trials
He L, Wang J, Ping F, et al.
JAMA Intern Med. 2022;182(5):513-9.
Leggi